Adam Wufsus/LinkedIn
Oct 3, 2026, 07:20
Adam Wufsus: Novo Nordisk Seeks Medical Liaison for Sickle Cell Disease
Adam Wufsus, Director, Medical Affairs – Rare Blood Disorders at Novo Nordisk, shared a post on LinkedIn:
“I’m pleased to share that I am hiring for an exciting opportunity at Novo Nordisk for a Medical Liaison passionate about advancing care for people living with sickle cell disease (SCD).
If you have a strong interest in SCD, a passion for medical affairs, and are looking to make a meaningful impact, I encourage you to explore this opportunity.”
Stay updated with Hemostasis Today.
-
Oct 3, 2026, 16:18Mira Kassouf: Reactivating An Embryonic Gene To Treat α-Thalassemia
-
Oct 3, 2026, 15:49Behnood Bikdeli: COATED_AIR Trial Design Published as Enrollment Reaches 3,000 Patients
-
Oct 3, 2026, 15:25Vanrose Panashe Nyamangodo: A Multi-Task Deep Learning Model For Malaria And Anemia
-
Oct 3, 2026, 14:52Benny Sorensen: Glanzmann’s Thrombasthenia Finally Assigned Dedicated ICD-10 Code
-
Oct 3, 2026, 14:52The Real-World Burden Of DVT In Traumatic Fractures – ISTH
-
Oct 3, 2026, 14:41How Much Do We Really Know About The Global Burden Of Venous Thromboembolism? – World Thrombosis Day
-
Oct 3, 2026, 14:35Nnadozie Gabriel C.: Understanding Hemophilia – Modern Breakthroughs and the Gap in Global Access
-
Oct 3, 2026, 14:26Björn Mulder: Differentiating PRP Formulations and Cell Counts in Knee and Ankle OA
-
Oct 3, 2026, 14:25Jorge Enrique: Personalised Strategies for Thrombosis Management in Cancer-Associated Cases